Journal article icon

Journal article

MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties

Abstract:
Alzheimer’s disease (AD) is the most common age-related form of dementia, associated with deposition of intracellular neuronal tangles consisting primarily of hyperphosphorylated microtubule-associated protein tau (p-tau) and extracellular plaques primarily comprising amyloid- β (Aβ) peptide. The p-tau tangle unit is a posttranslational modification of normal tau protein. Aβ is a neurotoxic peptide excised from the amyloid-β precursor protein (APP) by β-site APP-cleaving enzyme 1 (BACE1) and the γ-secretase complex. MicroRNAs (miRNAs) are short, single-stranded RNAs that modulate protein expression as part of the RNA-induced silencing complex (RISC). We identified miR-298 as a repressor of APP, BACE1, and the two primary forms of Aβ (Aβ40 and Aβ42) in a primary human cell culture model. Further, we discovered a novel effect of miR-298 on posttranslational levels of two specific tau moieties. Notably, miR-298 significantly reduced levels of ~55 and 50 kDa forms of the tau protein without significant alterations of total tau or other forms. In vivo overexpression of human miR-298 resulted in nonsignificant reduction of APP, BACE1, and tau in mice. Moreover, we identified two miR-298 SNPs associated with higher cerebrospinal fluid (CSF) p-tau and lower CSF Aβ42 levels in a cohort of human AD patients. Finally, levels of miR-298 varied in postmortem human temporal lobe between AD patients and age-matched non-AD controls. Our results suggest that miR-298 may be a suitable target for AD therapy
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/s41380-019-0610-2

Authors

More by this author
Role:
Author
ORCID:
0000-0001-9872-9366
More by this author
Role:
Author
ORCID:
0009-0008-8215-3524
More by this author
Role:
Author
ORCID:
0000-0003-2364-9649
More by this author
Role:
Author
ORCID:
0000-0002-7624-3872
More by this author
Role:
Author
ORCID:
0000-0001-7799-3416


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
Molecular Psychiatry More from this journal
Volume:
26
Issue:
10
Pages:
5636-5657
Publication date:
2020-01-15
DOI:
EISSN:
1476-5578
ISSN:
1359-4184


Language:
English
Keywords:
Pubs id:
1085155
Local pid:
pubs:1085155
Source identifiers:
W3000680274
Deposit date:
2026-02-12
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP